ABBV Competitors & Alternatives
Compare AbbVie Inc with similar stocks in the same industry
Drug Manufacturers - General
ABBV
Main Stock$248.00
Tradestie Score
59
Market Cap
$431.71B
P/E Ratio
122.2
Revenue Growth
0.1%
Analyst Upside
+6.0%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1181.87
|
$739.95B | 42.2 | 58 | Compare |
|
JNJ
Johnson & Johnson
|
$257.77
|
$448.07B | 29.8 | 58 | Compare |
|
NVO
Novo-Nordisk A/S
|
$49.28
|
$262.92B | 11.9 | 64 | Compare |
|
AZN
AstraZeneca PLC
|
$169.47
|
$261.56B | 25.8 | 51 | Compare |
|
NVS
Novartis AG
|
$153.37
|
$254.99B | 22.1 | 49 | Compare |
|
ABT
Abbott Laboratories
|
$92.11
|
$232.30B | 26.3 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$124.03
|
$225.13B | 34.8 | 59 | Compare |
|
AMGN
Amgen Inc
|
$360.45
|
$160.70B | 25.3 | 56 | Compare |
|
PFE
Pfizer Inc.
|
$24.48
|
$154.70B | 18.5 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$131.40
|
$137.92B | 17.7 | 64 | Compare |
More ABBV Analysis
Data updated: Jul 13, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry